Alice S Whittemore

Publications

• Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JC, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PD, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G. Br J Cancer. 2009; 100 (2): 412-20
• Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, Høgdall C, Blaakaer J, Easton DF, Ponder BA, Jacobs IJ, Menon U, Whittemore AS, Krüger-Kjaer S, Pearce CL, Pharoah PD, Gayther SA. Br J Cancer. 2009; 100 (6): 993-1001
• Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, Krüger Kjaer S, Hogdall E, Blaakaer J, Hogdall C, Easton DF, Song H, Pharoah PD, Whittemore AS, McGuire V, Quaye L, Anton-Culver H, Ziogas A, Terry KL, Cramer DW, Hankinson SE, Tworoger SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M. Cancer Res. 2009; 69 (6): 2349-57
• Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS, Song H, Hogdall E, Kjaer SK, Whittemore AS, DiCioccio R, Ramus SJ, Gayther SA, Schildkraut JM, Pharaoh PP, Sellers TA. Cancer Epidemiol Biomarkers Prev. 2009; 18 (3): 935-44
• Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, West DW, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2009; 18 (4): 1084-91
• Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O'Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore AS, West DW, John EM. Breast Cancer Res Treat. 2009; 117 (1): 167-76
• An admixture scan in 1,484 African American women with breast cancer. Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, Ingles SA, Ambrosone CB, Bovbjerg DH, Jandorf LH, Davis W, Ciupak G, Whittemore AS, Press MF, Ursin G, Bernstein L, Huntsman S, Henderson BE, Ziv E, Freedman ML. Cancer Epidemiol Biomarkers Prev. 2009; 18 (11): 3110-7
• No evidence of familial correlation in breast cancer metastasis. Whittemore AS, Stearman B, Venne V, Halpern J, Felberg A, McGuire V, Daly M, Buys SS. Breast Cancer Res Treat. 2009; 118 (3): 575-81
• Common variants on chromosome 6p22.1 are associated with schizophrenia. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, Gejman PV. Nature. 2009; 460 (7256): 753-7
• Significance levels for studies with correlated test statistics. Shi J, Levinson DF, Whittemore AS. Biostatistics. 2008; 9 (3): 458-66
• Multiple loci with different cancer specificities within the 8q24 gene desert. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM. J Natl Cancer Inst. 2008; 100 (13): 962-6
• Performance of BRCA1/2 mutation prediction models in Asian Americans. Kurian AW, Gong GD, Chun NM, Mills MA, Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, Ridge Y, Panabaker K, West DW, Whittemore AS, Ford JM. J Clin Oncol. 2008; 26 (29): 4752-8
• Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Song H, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore AS, Zheng W, Pharoah PD, Chenevix-Trench G, Pike MC, Schildkraut J, Berchuck A. Br J Cancer. 2008; 98 (2): 282-8
• Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study. Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L, Marchbanks PA, Burkman RT, Daling JR, Whittemore AS. Breast Cancer Res Treat. 2008; 109 (1): 157-64
• Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Song H, Koessler T, Ahmed S, Ramus SJ, Kjaer SK, Dicioccio RA, Wozniak E, Hogdall E, Whittemore AS, McGuire V, Ponder BA, Turnbull C, Hines S, Rahman N, Eeles RA, Easton DF, Gayther SA, Dunning AM, Pharoah PD. Cancer Res. 2008; 68 (21): 8837-42
• The effects of common genetic variants in oncogenes on ovarian cancer survival. Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakr J, Easton DF, Ponder BA, Jacobs I, Kjaer SK, Whittemore AS, Pearce CL, Pharoah PD, Song H. Clin Cancer Res. 2008; 14 (18): 5833-9
• Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. Mann A, Hogdall E, Ramus SJ, DiCioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Ponder BA, Kjaer SK, Gayther SA, Thompson DJ, Pharoah PD, Song H. Eur J Cancer. 2008; 44 (15): 2259-65
• Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Cancer Epidemiol Biomarkers Prev. 2008; 17 (1): 252-4
• Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients. Chan KE, Lafayette RA, Whittemore AS, Hlatky MA, Moran J. Nephrol Dial Transplant. 2008; 23 (9): 2948-56
• Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, Chenevix-Trench G, Chang-Claude J, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Edlund CK, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Kjaer SK, Hogdall CK, Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U, Moysich KB, Ness RB, Pearce CL, Pharoah PD, Pike MC, Ramus SJ, Rossing MA, Song H, Terada KY, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Berchuck A, Schildkraut JM. Cancer Epidemiol Biomarkers Prev. 2008; 17 (12): 3567-72
• Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Song H, Hogdall E, Ramus SJ, Dicioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Kjaer SK, Pharoah PD, Gayther SA. Clin Cancer Res. 2008; 14 (4): 1090-5
• Consortium analysis of 7 candidate SNPs for ovarian cancer. Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J, Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL. Int J Cancer. 2008; 123 (2): 380-8
• Imputation of missing ages in pedigree data. Balise RR, Chen Y, Dite G, Felberg A, Sun L, Ziogas A, Whittemore AS. Hum Hered. 2007; 63 (3-4): 168-74
• Assessing environmental modifiers of disease risk associated with rare mutations. Whittemore AS, Hum Hered. 2007; 63 (2): 134-43
• BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP. Am J Surg Pathol. 2007; 31 (1): 121-8
• Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Beesley J, Jordan SJ, Spurdle AB, Song H, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, McGuire V, Whittemore AS, Gayther SA, Pharoah PD, Webb PM, Chenevix-Trench G. Cancer Epidemiol Biomarkers Prev. 2007; 16 (12): 2557-65
• Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, Gayther SA, Pharoah PD. PLoS One. 2007; 2 (3): e268
• Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. John EM, Phipps AI, Knight JA, Milne RL, Dite GS, Hopper JL, Andrulis IL, Southey M, Giles GG, West DW, Whittemore AS. Int J Cancer. 2007; 121 (2): 386-94
• Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online. Ramus SJ, Harrington PA, Pye C, Peock S, Cook MR, Cox MJ, Jacobs IJ, DiCioccio RA, Whittemore AS, Piver MS, EMBRACE, Easton DF, Ponder BA, Pharoah PD, Gayther SA. Hum Mutat. 2007; 28 (5): 525-6
• Multiple regions within 8q24 independently affect risk for prostate cancer. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D. Nat Genet. 2007; 39 (5): 638-44
• Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, Green AC, Whiteman DC, Goodman MT, Lurie G, Carney ME, Modugno F, Ness RB, Edwards RP, Moysich KB, Goode EL, Couch FJ, Cunningham JM, Sellers TA, Wu AH, Pike MC, Iversen ES, Marks JR, Garcia-Closas M, Brinton L, Lissowska J, Peplonska B, Easton DF, Jacobs I, Ponder BA, Schildkraut J, Pearce CL, Chenevix-Trench G, Berchuck A, Pharoah PD. Cancer Res. 2007; 67 (7): 3027-35
• Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Isaacs WB. Hum Mol Genet. 2007; 16 (11): 1271-8
• UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women. Hong AL, Huo D, Kim HJ, Niu Q, Fackenthal DL, Cummings SA, John EM, West DW, Whittemore AS, Das S, Olopade OI. Drug Metab Dispos. 2007; 35 (8): 1254-61
• Comparison of admixture and association mapping in admixed families. Clarke G, Whittemore AS. Genet Epidemiol. 2007; 31 (7): 763-75
• Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Hum Mutat. 2007; 28 (12): 1207-15
• Prediagnostic C-peptide and risk of prostate cancer. Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Cancer Epidemiol Biomarkers Prev. 2007; 16 (10): 2164-5
• Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, West DW, Whittemore AS. JAMA. 2007; 298 (24): 2869-76
• Disengagement and social support moderate distress among women with a family history of breast cancer. Turner-Cobb JM, Bloor LE, Whittemore AS, West D, Spiegel D. Breast J. 2006 Jan-Feb; 12 (1): 7-15
• Common variants in RB1 gene and risk of invasive ovarian cancer. Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK, Dicioccio RA, Dunning AM, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Lesueur F, Easton DF, Jacobs IJ, Ponder BA, Gayther SA, Pharoah PD. Cancer Res. 2006; 66 (20): 10220-6
• Predicting and preventing hereditary colorectal cancer. Ford JM, Whittemore AS. JAMA. 2006; 296 (12): 1521-3
• Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Hum Mutat. 2006; 27 (11): 1122-8
• Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D. Proc Natl Acad Sci U S A. 2006; 103 (38): 14068-73
• Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, Bishop DT, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh CL, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TL, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA. Hum Genet. 2006; 120 (4): 471-85
• Short-term chloral hydrate administration and cancer in humans. Haselkorn T, Whittemore AS, Udaltsova N, Friedman GD. Drug Saf. 2006; 29 (1): 67-77
• Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors. Zhang MM, Cheung MK, Osann K, Lee MM, Lin Gomez SS, Whittemore AS, Husain A, Teng NN, Chan JK. Obstet Gynecol. 2006; 107 (2 Pt 1): 329-35
• Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes? Chan JK, Manuel MR, Cheung MK, Osann K, Husain A, Teng NN, Rao A, Carlson RW, Whittemore AS. Gynecol Oncol. 2006; 102 (3): 508-12
• Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2006; 15 (2): 359-63
• Nonparametric linkage analysis using person-specific covariates. Whittemore AS, Halpern J. Genet Epidemiol. 2006; 30 (5): 369-79
• No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2006; 15 (8): 1565-7
• Patterns and progress in ovarian cancer over 14 years. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K. Obstet Gynecol. 2006; 108 (3 Pt 1): 521-8
• An inverse association between ovarian cysts and breast cancer in the breast cancer family registry. Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ, Giles GG, Ziogas A, Andrulis IL, Whittemore AS, Hopper JL. Int J Cancer. 2006; 118 (1): 197-202
• The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry. Bernstein JL, Teraoka SN, John EM, Andrulis IL, Knight JA, Lapinski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P. Cancer Epidemiol Biomarkers Prev. 2006; 15 (2): 348-52
• BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2006; 15 (10): 1863-70
• Common variants in mismatch repair genes and risk of invasive ovarian cancer. Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, Ponder BA, Kjaer SK, Pharoah PD, Gayther SA. Carcinogenesis. 2006; 27 (11): 2235-42
• Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States). Tsai CJ, Cohn BA, Cirillo PM, Feldman D, Stanczyk FZ, Whittemore AS. Cancer Causes Control. 2006; 17 (10): 1237-44
• Getting more from digital SNP data. El Karoui N, Zhou W, Whittemore AS. Stat Med. 2006; 25 (18): 3124-33
• Histologic types of epithelial ovarian cancer: have they different risk factors? Kurian AW, Balise RR, McGuire V, Whittemore AS. Gynecol Oncol. 2005; 96 (2): 520-30
• Covariate adjustment in family-based association studies. Whittemore AS, Halpern J, Ahsan H. Genet Epidemiol. 2005; 28 (3): 244-55
• Genetic association studies: time for a new paradigm? Whittemore AS, Cancer Epidemiol Biomarkers Prev. 2005; 14 (6): 1359-60
• Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans. Whittemore AS, Cirillo PM, Feldman D, Cohn BA. J Urol. 2005; 174 (3): 872-6; discussion 876
• Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Haselkorn T, Whittemore AS, Lilienfeld DE. Cancer Causes Control. 2005; 16 (7): 781-7
• A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D. Am J Hum Genet. 2005; 77 (2): 219-29
• Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, Pharoah PD. Int J Cancer. 2005; 117 (4): 611-8
• Re: Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? Whittemore AS, J Natl Cancer Inst. 2005; 97 (5): 400; author reply 400-1
• Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2005; 14 (2): 350-6
• Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study. Ahsan H, Whittemore AS, Chen Y, Senie RT, Hamilton SP, Wang Q, Gurvich I, Santella RM. Breast Cancer Res. 2005; 7 (1): R71-81
• Response to C. Bosetti et al. (Trends in colorectal cancer mortality in Japan, 1970-2000). Yiu HY, Whittemore AS, Shibata A. Int J Cancer. 2005; 113 (2): 342
• Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Int J Gynecol Pathol. 2004; 23 (1): 29-34
• The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D. Breast Cancer Res. 2004; 6 (4): R375-89
• Increasing colorectal cancer incidence rates in Japan. Yiu HY, Whittemore AS, Shibata A. Int J Cancer. 2004; 109 (5): 777-81
• A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, Santella RM. Breast Cancer Res Treat. 2004; 85 (2): 121-31
• The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity. Ostrow KL, McGuire V, Whittemore AS, DiCioccio RA. Cancer Genet Cytogenet. 2004; 153 (2): 177-80
• Classifying disease chromosomes arising from multiple founders, with application to fine-scale haplotype mapping. Yu K, Martin RB, Whittemore AS. Genet Epidemiol. 2004; 27 (3): 173-81
• STK15 polymorphisms and association with risk of invasive ovarian cancer. Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S. Cancer Epidemiol Biomarkers Prev. 2004; 13 (10): 1589-94
• Breast cancer risks for BRCA1/2 carriers. Easton DF, Hopper JL, Thomas DC, Antoniou A, Pharoah PD, Whittemore AS, Haile RW. Science. 2004; 306 (5705): 2187-91; author reply 2187-91
• Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Nguyen MH, Whittemore AS, Garcia RT, Tawfeek SA, Ning J, Lam S, Wright TL, Keeffe EB. Clin Gastroenterol Hepatol. 2004; 2 (9): 820-4
• Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS. Br J Cancer. 2004; 91 (11): 1911-5
• Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW. Cancer Epidemiol Biomarkers Prev. 2004; 13 (12): 2078-83
• Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2004; 13 (8): 1325-30
• Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, West DW, Whittemore AS. Am J Epidemiol. 2004; 160 (7): 613-8
• BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA. Cancer Res. 2003; 63 (2): 417-23
• Logistic regression of family data from retrospective study designs. Whittemore AS, Halpern J. Genet Epidemiol. 2003; 25 (3): 177-89
• Where are the prostate cancer genes?--A summary of eight genome wide searches. Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ. Prostate. 2003; 57 (4): 261-9
• Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Am J Public Health. 2003; 93 (10): 1753-9
• Breast cancer in Marin County. Whittemore AS, Breast Cancer Res. 2003; 5 (5): 232-4
• Genetic association tests for family data with missing parental genotypes: a comparison. Whittemore AS, Halpern J. Genet Epidemiol. 2003; 25 (1): 80-91
• Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene. Gong G, Whittemore AS. Genet Epidemiol. 2003; 24 (3): 173-80
• Observational studies and randomized trials of hormone replacement therapy: what can we learn from them? Whittemore AS, McGuire V. Epidemiology. 2003; 14 (1): 8-10
• Re: On the use of familial aggregation in population-based case probands for calculating penetrance. Whittemore AS, Gong G. J Natl Cancer Inst. 2003; 95 (1): 76-7; author reply 77-8
• Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. McGuire V, Herrinton L, Whittemore AS. Epidemiology. 2002; 13 (2): 231-4
• Survival among U.S. women with invasive epithelial ovarian cancer. McGuire V, Jesser CA, Whittemore AS. Gynecol Oncol. 2002; 84 (3): 399-403
• Tests for genetic association using family data. Shih MC, Whittemore AS. Genet Epidemiol. 2002; 22 (2): 128-45
• Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Cancer Causes Control. 2002; 13 (5): 471-82
• Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue. Bernstein JL, Thompson WD, Casey G, DiCioccio RA, Whittemore AS, Diep AT, Thakore SS, Vaziri S, Xue S, Haile RW. Cancer Epidemiol Biomarkers Prev. 2002; 11 (9): 809-14
• Analysis of the human progesterone receptor gene polymorphism PROGINS in Austrian ovarian cancer patients. Whittemore AS, McGuire V. Int J Cancer. 2002; 101 (2): 202; author reply 203
• Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS. Hum Mutat. 2002; 20 (1): 65-73
• Carbohydrates and colorectal cancer risk among Chinese in North America. Borugian MJ, Sheps SB, Whittemore AS, Wu AH, Potter JD, Gallagher RP. Cancer Epidemiol Biomarkers Prev. 2002; 11 (2): 187-93
• Problems in the definition, interpretation, and evaluation of genetic heterogeneity. Whittemore AS, Halpern J. Am J Hum Genet. 2001; 68 (2): 457-65
• Allele-sharing among affected relatives: non-parametric methods for identifying genes. Shih MC, Whittemore AS. Stat Methods Med Res. 2001; 10 (1): 27-55
• Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Horn-Ross PL, Morris JS, Lee M, West DW, Whittemore AS, McDougall IR, Nowels K, Stewart SL, Spate VL, Shiau AC, Krone MR. Cancer Epidemiol Biomarkers Prev. 2001; 10 (9): 979-85
• Re: Prostate cancer incidence and mortality in the United States and the United Kingdom. Shibata A, Whittemore AS. J Natl Cancer Inst. 2001; 93 (14): 1109-10
• Detection of disease genes by use of family data. II. Application to nuclear families. Tu IP, Balise RR, Whittemore AS. Am J Hum Genet. 2000; 66 (4): 1341-50
• Correction Whittemore AS, Stat Med. 2000; 19 (9): 1251
• Survival in epithelial ovarian cancer patients with prior breast cancer. McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Am J Epidemiol. 2000; 152 (6): 528-32
• Prostate cancer risk in relation to anthropometry and physical activity: the National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study. Clarke G, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2000; 9 (9): 875-81
• Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Gnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS. Epidemiology. 2000; 11 (2): 102-5
• Detection of disease genes by use of family data. I. Likelihood-based theory. Whittemore AS, Tu IP. Am J Hum Genet. 2000; 66 (4): 1328-40
• Differences in socioeconomic status and survival among white and black men with prostate cancer. Robbins AS, Whittemore AS, Thom DH. Am J Epidemiol. 2000; 151 (4): 409-16
• Study design in genetic epidemiology: theoretical and practical considerations. Whittemore AS, Nelson LM. J Natl Cancer Inst Monogr. 1999; (26): 61-9
• The Eighth AACR American Cancer Society Award lecture on cancer epidemiology and prevention. Genetically tailored preventive strategies: an effective plan for the twenty-first century? American Association for Cancer Research. Whittemore AS, Cancer Epidemiol Biomarkers Prev. 1999; 8 (8): 649-58
• Estimating genetic influence on disease from population-based case-control data: application to cancers of the breast and ovary. Gong G, Whittemore AS. Stat Med. 1999; 18 (23): 3321-36
• Multipoint linkage analysis. A cautionary note. Halpern J, Whittemore AS. Hum Hered. 1999; 49 (4): 194-6
• Power of association and linkage tests when the disease alleles are unobserved. Tu IP, Whittemore AS. Am J Hum Genet. 1999; 64 (2): 641-9
• Prostate cancer incidence and mortality in the United States and the United Kingdom. Shibata A, Ma J, Whittemore AS. J Natl Cancer Inst. 1998; 90 (16): 1230-1
• Simple, robust linkage tests for affected sibs. Whittemore AS, Tu IP. Am J Hum Genet. 1998; 62 (5): 1228-42
• Race, prostate cancer survival, and membership in a large health maintenance organization. Robbins AS, Whittemore AS, Van Den Eeden SK. J Natl Cancer Inst. 1998; 90 (13): 986-90
• Multi-stage sampling in genetic epidemiology. Whittemore AS, Halpern J. Stat Med. 1997 Jan 15-Feb 15; 16 (1-3): 153-67
• Serum levels of prostate-specific antigen among Japanese-American and native Japanese men. Shibata A, Whittemore AS, Imai K, Kolonel LN, Wu AH, John EM, Stamey TA, Paffenbarger RS. J Natl Cancer Inst. 1997; 89 (22): 1716-20
• Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Whittemore AS, Gong G, Itnyre J. Am J Hum Genet. 1997; 60 (3): 496-504
• Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Shibata A, Whittemore AS. Prostate. 1997; 32 (1): 65-72
• Genome scanning for linkage: an overview. Whittemore AS, Am J Hum Genet. 1996; 59 (3): 704-16
• Vasectomy and prostate cancer: results from a multiethnic case-control study. John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ. J Natl Cancer Inst. 1995; 87 (9): 662-9
• Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW. J Natl Cancer Inst. 1995; 87 (9): 652-61
• Prostate-specific antigen as predictor of prostate cancer in black men and white men. Whittemore AS, Lele C, Friedman GD, Stamey T, Vogelman JH, Orentreich N. J Natl Cancer Inst. 1995; 87 (5): 354-60
• Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Am J Epidemiol. 1995; 141 (8): 732-40
• Chronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANES. Whittemore AS, Perlin SA, DiCiccio Y. Am J Public Health. 1995; 85 (5): 702-6
• A class of tests for linkage using affected pedigree members. Whittemore AS, Halpern J. Biometrics. 1994; 50 (1): 118-27
• Probability of gene identity by descent: computation and applications. Whittemore AS, Halpern J. Biometrics. 1994; 50 (1): 109-17
• Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview. Kelsey JL, Whittemore AS. Ann Epidemiol. 1994; 4 (2): 89-95
• Use of biological markers in risk assessment. McMillan A, Whittemore AS, Silvers A, DiCiccio Y. Risk Anal. 1994; 14 (5): 807-13
• Comparison of dietary habits, physical activity and body size among Chinese in North America and China. Lee MM, Wu-Williams A, Whittemore AS, Zheng S, Gallagher R, Teh CZ, Zhou L, Wang X, Chen K, Ling C. Int J Epidemiol. 1994; 23 (5): 984-90
• Prostate cancer. Whittemore AS, Cancer Surv. 1994: 19-20 309-22
• Characteristics relating to ovarian cancer risk: implications for prevention and detection. Whittemore AS, Gynecol Oncol. 1994; 55 (3 Pt 2): S15-9
• Segregation analysis of case-control data using generalized estimating equations. Whittemore AS, Gong G. Biometrics. 1994; 50 (4): 1073-87
• Fertility drugs and risk of ovarian cancer. Whittemore AS, Hum Reprod. 1993; 8 (7): 999-1000
• Use of NHANES data to assign nutrient densities to food groups in a multiethnic diet history questionnaire. Dreon DM, John EM, DiCiccio Y, Whittemore AS. Nutr Cancer. 1993; 20 (3): 223-30
• Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in the United States. Whittemore AS, Cancer. 1993; 71 (2 Suppl): 558-65
• Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. John EM, Whittemore AS, Harris R, Itnyre J. J Natl Cancer Inst. 1993; 85 (2): 142-7
• Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Cancer. 1993; 71 (3 Suppl): 933-8
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Whittemore AS, Harris R, Itnyre J. Am J Epidemiol. 1992; 136 (10): 1212-20
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Harris R, Whittemore AS, Itnyre J. Am J Epidemiol. 1992; 136 (10): 1204-11
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Whittemore AS, Harris R, Itnyre J. Am J Epidemiol. 1992; 136 (10): 1184-203
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. Whittemore AS, Harris R, Itnyre J, Halpern J. Am J Epidemiol. 1992; 136 (10): 1175-83
• Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties. Gong G, Whittemore AS, West D, Moore DH. Cancer Causes Control. 1992; 3 (3): 191-7
• Low-grade, latent prostate cancer volume: predictor of clinical cancer incidence? Whittemore AS, Keller JB, Betensky R. J Natl Cancer Inst. 1991; 83 (17): 1231-5
• Family data determine all parameters in Mendelian incomplete penetrance models. Whittemore AS, Keller JB, Ward MJ. Ann Hum Genet. 1991; 55 (Pt 2): 175-7
• Urinary cadmium and blood pressure: results from the NHANES II survey. Whittemore AS, DiCiccio Y, Provenzano G. Environ Health Perspect. 1991: 91 133-40
• The importance of models in the assessment of synergy. Hlatky MA, Whittemore AS. J Clin Epidemiol. 1991; 44 (12): 1287-8
• Diet, physical activity, and colorectal cancer among Chinese in North America and China. Whittemore AS, Wu-Williams AH, Lee M, Zheng S, Gallagher RP, Jiao DA, Zhou L, Wang XH, Chen K, Jung D. J Natl Cancer Inst. 1990; 82 (11): 915-26
• Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. Whittemore AS, Holly EA, Lee IM, Abel EA, Adams RM, Nickoloff BJ, Bley L, Peters JM, Gibney C. J Natl Cancer Inst. 1989; 81 (20): 1560-7
• Colorectal cancer incidence among Chinese in North America and the People's Republic of China: variation with sex, age and anatomical site. Whittemore AS, Int J Epidemiol. 1989; 18 (3): 563-8
• Cancer risk assessment and prevention: where do we stand? Whittemore AS, Environ Health Perspect. 1989: 81 95-101
• Epithelial ovarian cancer and the ability to conceive. Whittemore AS, Wu ML, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J. Cancer Res. 1989; 49 (14): 4047-52
• Effect of cigarette smoking in epidemiological studies of lung cancer. Whittemore AS, Stat Med. 1988 Jan-Feb; 7 (1-2): 223-38
• Body size, reproductive factors, and breast cancer survival. Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS. Prev Med. 1988; 17 (5): 634-42
• Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Wu ML, Whittemore AS, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J. Am J Epidemiol. 1988; 128 (6): 1216-27
• Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk. Kampert JB, Whittemore AS, Paffenbarger RS. Am J Epidemiol. 1988; 128 (5): 962-79
• Errors in reported dietary intakes. II. Long-term recall. Wu ML, Whittemore AS, Jung DL. Am J Epidemiol. 1988; 128 (5): 1137-45
• Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Whittemore AS, Wu ML, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M. Am J Epidemiol. 1988; 128 (6): 1228-40
• Methods old and new for analyzing occupational cohort data. Whittemore AS, Am J Ind Med. 1987; 12 (3): 233-48
• Methods for analyzing occupational cohort data with application to lung cancer in U.S. uranium miners. Halpern J, Whittemore AS. J Chronic Dis. 1987: 40 Suppl 2 79S-88S
• Errors in reported dietary intakes. I. Short-term recall. Wu ML, Whittemore AS, Jung DL. Am J Epidemiol. 1986; 124 (5): 826-35